Clinical Edge Journal Scan

Clinical Edge Journal Scan

Tirzepatide vs. insulin glargine improves renal outcomes in T2D

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Commentary: Preventing and Predicting T2D Complications, October 2022

Publish date: September 23, 2022

• Read More

Clinical Edge Journal Scan

Mean A1c and A1c variability independently predict diabetes-related complications in T2D

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

Long-term SGLT2 inhibitor use may lower new-onset stroke risk in T2D

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

Increased variability in A1c and FPG is a risk factor for severe hypoglycemia

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

SGLT2i vs DPP4i tied with reduced mortality and HF readmission risk in T2D patients with HF

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

Effect of DPP4 inhibitors on glycemic variability in T2D

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

No effect of SGLT-2 inhibitors on cardiac autonomic neuropathy indices in T2D

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

Treatment advancement with iGlarLixi as effective as BI+RAI in real world in T2D

Publish date: September 16, 2022

• Read More

Clinical Edge Journal Scan

Dapagliflozin prevents kidney function decline in T2D

Publish date: September 16, 2022

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »